Erica Hardy

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned”.

National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned

Annals of Internal Medicine(2024)10.7326/annals-24-00464

N/A

0.574DataRank · unranked

45 citations

Alice K. Pau, Eric S. Daar, Laura Evans, Rajesh T. Gandhi, Pablo Tebas +61 more

Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing for Obstetric Inpatient Units Across the United States

Clinical Infectious Diseases(2021)10.1093/cid/ciab955

N/A

0DataRank · unranked

1 citations

Namita Kansal, Joseph Biggio, Shani Delaney, Chad A. Grotegut, Erica Hardy +15 more

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness

Clinical Infectious Diseases(2025)10.1093/cid/ciaf424

N/A

0DataRank · unranked

4 citations

Yngve Falck–Ytter, Lindsey R. Baden, Roger Bedimo, Kelly Cawcutt, Vincent Chi‐Chung Cheng +24 more

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab

Clinical Infectious Diseases(2025)10.1093/cid/ciaf235

N/A

0DataRank · unranked

1 citations

Adarsh Bhimraj, Kelly Cawcutt, Kathleen Chiotos, Amy Dzierba, Arthur Y Kim +24 more

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab

Clinical Infectious Diseases(2025)10.1093/cid/ciaf355

N/A

0DataRank · unranked

1 citations

Adarsh Bhimraj, Kelly Cawcutt, Kathleen Chiotos, Amy Dzierba, Arthur Y Kim +24 more